CompletedPhase 1NCT02685852
Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
Studying Congenital isolated hyperinsulinism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Minnesota
- Principal Investigator
- Shalamar D Sibley, MDUniversity of Minnesota
- Intervention
- Exenatide(drug)
- Enrollment
- 11 enrolled
- Eligibility
- 18-60 years · All sexes
- Timeline
- 2016 – 2019
Study locations (1)
- University of Minnesota Medical Center, Minneapolis, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02685852 on ClinicalTrials.gov